Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists

Hundreds Reach Out to BBC About ‘Hell’ Skin Condition, Yet Medical Experts Remain Divided

A recent BBC News piece explored the growing concern surrounding a severe skin condition, dubbed “hell” by some, which has sparked debates among healthcare professionals. The condition, known as topical steroid withdrawal (TSW), is often linked to eczema but is not universally accepted as a distinct disorder. Despite its prevalence in online discussions, doctors are still uncertain about its nature and diagnosis. The story resonated deeply with readers, drawing over two million views and 240 responses from individuals sharing their experiences.

The Patient’s Story

Bethany Norman, a 36-year-old mother, described her ordeal with TSW after refusing steroid creams for her son’s eczema. “Look at what this medication has done to me? Why would I put it on my own son?” she recalled shouting while holding her newborn in hospital. Her skin had become a battlefield—open sores, unrelenting itch, and constant shedding left her feeling trapped. She believed the steroid creams she used for years had triggered TSW, and she refused to let her baby suffer the same fate.

“I’ve been told by countless medics that all I have is a severe flare up of eczema and steroid creams will sort it. They just made it worse,” Norman said.

Medical Perspectives

For decades, steroid creams have been a cornerstone of eczema treatment, ranging from mild hydrocortisone to stronger prescription variants. Yet, a growing number of patients claim these treatments worsen their symptoms. Dr. Pippa Bowes, an urgent care specialist in Southampton, highlighted the communication challenges: “There can be a breakdown of understanding. Patients sometimes feel unheard, and doctors struggle to grasp what’s happening.”

Jenna Crosbie, a trainee GP in north Wales, initially found it puzzling that a patient would reject steroids. “Everything I learned said these were essential for eczema,” she explained. But after noticing her own skin flares changing, she began to question the standard approach. Using more potent creams during night shifts led to spreading redness, prompting her to research and realize her symptoms differed from typical eczema.

“I wouldn’t wish it on my worst enemy,” Crosbie added.

Questions and Concerns

Dr. Dean Eggit, a GP in Doncaster, raised concerns about overprescription. “Steroid creams are vital, but they can be misused,” he noted. He suggested that doctors might prescribe them too quickly without investigating underlying causes. “The early stages of TSW can resemble eczema, making it hard to identify,” he explained. “This risk means we could be unintentionally perpetuating the condition.”

Guidelines from NICE recommend a gradual approach to eczema treatment, starting with emollients before using steroids. However, the absence of clear protocols leaves some patients without proper support. As research continues, the divide between patients and medical professionals grows, with trust eroding over the condition’s true nature and management.